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Introduction: Fetal hemoglobin is an important factor in modulating the severity of sickle cell anemia. 
Its level in peripheral blood underlies strong genetic determination. Associated loci with increased levels 
of fetal hemoglobin display population-specific allele frequencies. 
Objective: We investigated the presence and effect of known common genetic variants promoting 
fetal hemoglobin persistence (rs11886868, rs9399137, rs4895441, and rs7482144) in 60 Colombian 
patients with sickle cell anemia. 
Materials and methods: Four single nucleotide polymorphisms (SNP) were genotyped by restriction 
fragment length polymorphisms (RFLP) and the use of the TaqMan procedure. Fetal hemoglobin (HbF) 
from these patients was quantified using the oxyhemoglobin alkaline denaturation technique. Genotype 
frequencies were compared with frequencies reported in global reference populations. 
Results: We detected genetic variants in the four SNPs, reported to be associated with higher HbF 
levels for all four SNPs in the Colombian patients. Genetic association between SNPs and HbF levels 
did not reach statistical significance. The frequency of these variants reflected the specific ethnic make-
up of our patient population: A high prevalence of rs7482144-‘A’ reflects the West-African origin of the 
sickle cell mutation, while high frequencies of rs4895441-‘G’ and rs11886868-‘C’ point to a significant 
influence of an Amerindian ethnic background in the Colombian sickle cell disease population. 
Conclusion: These results showed that in the sickle cell disease population in Colombia there is 
not a unique genetic background, but two (African and Amerindian). This unique genetic situation will 
provide opportunities for a further study of these loci, such as fine-mapping and molecular-biological 
investigation. Colombian patients are expected to yield a distinctive insight into the effect of modifier 
loci in sickle cell disease. 
Key words: Fetal hemoglobin, polymorphism, single nucleotide; anemia, sickle cell; admixture, beta-
globin cluster, BCL11A, HBS1L-MYB. 
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Las variantes genéticas asociadas con niveles de hemoglobina fetal señalan diversos orígenes 
étnicos en pacientes colombianos con anemia falciforme.
Introducción. La hemoglobina fetal es un importante factor modulador de la gravedad de la anemia 
falciforme, cuya expresión está muy condicionada por el factor genético. Los loci asociados con                  
el incremento de la hemoglobina fetal pueden presentar frecuencias alélicas específicas para                 
cada población.
Objetivo. Investigar la presencia y el efecto de las variantes genéticas rs11886868, rs9399137, 
rs4895441 y rs7482144 asociadas con la persistencia de hemoglobina fetal, en 60 pacientes 
colombianos con anemia falciforme. 
Materiales y métodos. Se hizo la genotipificación de los polimorfismos de nucleótido simple (Single 
Nucleotide Polymorphisms, SNP) mediante la técnica de polimorfismos de longitud de fragmentos 
de restricción (Restriction Fragment Length Polymorphisms, RFLP) y el procedimiento TaqMan. 
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Guillermo Barreto designed and supervised the study. 
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Stephan Menzel analyzed and interpreted the data.
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La hemoglobina fetal (HbF) se cuantificó utilizando la técnica de desnaturalización alcalina de la 
oxihemoglobina. Las frecuencias genotípicas se compararon con las reportadas en poblaciones de 
referencia global. 
Resultados. Se observaron variantes genéticas ya reportadas para aumento de HbF en los cuatro SNP. 
La asociación genética entre los SNP y el incremento de la HbF no alcanzó significancia estadística. 
La frecuencia de estos alelos reflejó la siguiente composición específica en esta muestra de pacientes 
colombianos: una gran prevalencia de rs7482144-‘A’, lo que indica que el origen de la mutación para 
la anemia falciforme es África occidental, y una gran frecuencia de rs4895441-‘G’ y rs11886868-‘C’, lo 
que denota la influencia significativa del origen genético amerindio. 
Conclusión. Los resultados evidenciaron que la población con anemia falciforme de Colombia no 
tiene un único origen genético, sino que existen dos (africano y amerindio). Esta situación genética 
única ofrece la oportunidad de llevar a cabo un estudio más amplio de estos loci a nivel molecular. 
Se espera que el estudio de pacientes colombianos permita una visión diferente del efecto de los loci 
modificadores en esta enfermedad.
Palabras claves: hemoglobina fetal, polimorfismos de nucléotido simple, anemia falciforme, diversidad 
étnica, globinas beta, BCL11A, HBS1L-MYB. 
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Fetal hemoglobin (HbF) (γ2α2) is present in human 
red blood cells from the sixth week of gestation, 
but is replaced by adult hemoglobin starting from 
just before birth (1). In some individuals, significant 
amounts of HbF continue to be produced during 
adulthood. This is of clinical significance when it 
happens in patients with beta-thalassemia and 
sickle cell anemia, resulting in a reduced disease 
severity and mortality. HbF levels are largely deter-
mined by the number of a sub-set of red blood cells 
termed ‘F cells’ (HbF-containing erythrocytes). 
In healthy individuals, F cell levels are largely 
genetically determined, with a heritability of 89% 
(2). In beta-globin gene disorders, such as beta-
thalassemia and sickle cell disease, F cells and HbF 
are usually elevated due to stress erythropoiesis, 
but can be further boosted by common genetic 
factors. In addition to F-cell levels, factors directly 
influencing the expression of HBG1 and HBG2, 
the genes encoding the specific gamma chain of 
HbF, contribute to peripheral HbF variability. 
Some common genetic variants at quantitative 
trait loci (QTL) for F cells and HbF have been 
identified. Sequence variants within the beta-globin 
gene cluster affect the expression of HBG1 and 
HBG2, which encode the gamma chain of fetal 
hemoglobin, such as rs7482144 (also termed 
XmnI Gγ), a polymorphism within the promoter of 
HBG2. Two regions with significant influence on 
HbF levels have been discovered outside the beta-
globin cluster. BCL11A encodes a transcription 
factor that regulates gamma globin production and 
SNPs within intronic regulatory sequences that 
influence HbF levels in healthy individuals and 
hemoglobinopathy patients. The second region, 
HBS1L-MYB, contains a series of sequence 
variants that alter upstream regulative regions for 
MYB, which encode a transcription factor essential 
to erythropoiesis. These variants occur in two sub-
loci, HMIP-A and HMIP-2B, that map to distinct 
enhancer elements for MYB (3,4, Menzel, et al., 
manuscript in preparation). HbF-increasing alleles 
at all three regions loci have subsequently been 
shown to alleviate the severity of sickle cell anemia 
and beta-thalassemia (5,6). Additional QTLs have 
been detected on chromosomes 8 and X through 
linkage analysis but have not been mapped in 
detail (7). HbF QTLs display population-specific 
allele frequencies and, hence, their individual 
importance differs among major population groups 
and, therefore, in countries. 
Sickle cell anemia, a globin disorder mainly of Sub-
Saharan African origin, is prevalent in Colombia 
(8,9), which has a significant African-descendant 
population component, in addition to European and 
Amerindian constituents. The significant genetic 
admixture of Colombian patient groups means that 
little is known about the presence and frequency 
of the disease modifier variants at the HbF QTLs.
The present study determined the frequency of 
variants at the three main known sickle cell disease 
modifier loci in a sample of patients from Colombia: 
for rs11886868 at BCL11A gene; for rs9399137 
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and rs4895441 at HBS1L-MYB; and for rs7482144 
at the beta-globin gene cluster. These SNPs have 
been found to be consistently associated with 
HbF in diverse populations and groups of patients 
with sickle cell disease (5,10-13). Our group of 
60 patients was not large enough for a formal 
association analysis, but sufficient to gain insight 
into the presence of known protective variants as 
a first step towards a future contribution of genetic 
research to clinical management and prognosis 
of patients.
Materials and methods
Sample
Blood samples were collected from 60 individuals 
(30 female, 30 male) who had been classified as 
positive for sickle cell hemoglobin (Hb S) (with a 
metabisulfite test) in Hospital San Jerónimo in 
Montería (Department of Córdoba), and Hospital 
Napoleón Franco in Cartagena (Department of 
Bolívar), both located in the Colombian Atlantic 
Coast, and Hospital Regional de Buenaventura 
(Buenaventura) and Hospital Universitario del Valle, 
HUV (Cali), both in the Colombian Pacific Coast 
(Department of Valle del Cauca). Out of those 
samples, 19 were from the Pacific Coast, and 41 
from the Atlantic Coast. 
The participant’s age range was from 2 to 45 
years. An age cut-off of >2 years was applied so 
that “adult-type” HbF production would not be 
confounded with residual “fetal-type” HbF synthesis 
present during the perinatal period. 
Most of the patients were recruited during non-
acute visits to the hospitals in the cities where 
the study took place, and none were in sickle 
crisis at the time of sampling. The participants 
had not received blood transfusions during the 
three months before the samples were taken. 
The samples were taken after parents or patients 
gave written informed consent. This research was 
approved by the ethic board of the Universidad del 
Valle (Approval act 09-09).
Quantification of HbF in whole blood
HbF was quantified using the oxyhemoglobin alka-
line denaturation technique (14,15). For this, all 
hemoglobin, except HbF, present in the hemolysate 
underwent denaturation in an alkaline medium. After 
the precipitation and filtration of this hemolysate, the 
HbF recovered was quantified by spectrophotometry 
at 450nm.
Molecular diagnosis of HbS
DNA was extracted using the salting-out technique 
(16). The genotype at the HbS locus was determined 
using a PCR-RFLP assay, as described in one of 
our previous studies (17). This method of diagnosis 
for sickle cell anemia made possible to exclude 
patients with heterozygous genotype such as 
HbSC or HbSβ thal+; however, patients with HbS/β 
thal
0 
genotype due to beta gene deletion could not 
be excluded. 
SNP genotyping
For SNP genotyping of rs9399137, rs4895441 
and rs11886868, we used TaqMan assays (18) 
(Applied Biosystem, Foster City, California) run 
on a TaqMan 7900 real-time PCR instrument 
(Applied Biosystems) with supplier-recommended 
procedures. For SNP rs7482144, a restriction 
digestion with Xmn I was carried out after PCR. 
The primers used for this region were Forward 
5’CAGGCCTCACTGGAGCTACAGAC and Reverse 
5’ACCTCAGACGTTCCAGAAGCGAGT, which had 
been designed using the PRIMER3 software (19). 
The PCR mix contained 50 ng of genomic DNA in 
a 25 �l volume with 0,12 uM each primer, 0.01 mM 
total of dNTP’s 1X TRIS-HCl, pH 8.4, 50 mM KCl, 
1 mM MgCl2 and 1unit of Taq polymerase (Bioline, 
London, United Kingdom). The PCR conditions were 
as follows: Initial denaturation at 92° for 5 min, 30 
cycles with denaturation at 93° for 1 min, annealing 
at 68° for 1 min and extension at 72 for 1.5 min and 
a final cycle extension was prolonged to 3 min. 
Data analysis
Observed frequencies were compared with those 
reported by HapMap for reference populations 
and The 1000 Genomes Project (20,21). The 
association of SNP alleles with HbF levels was 
evaluated by linear regression, with age and sex 
as covariates. Association was also tested with a 
joint ‘SNP score’ (22). Allele frequencies between 
populations were compared using chi-square test. 
All analysis were performed using Statistica 8.0 
(23) and Arlequin software (24).
Results
We genotyped representative SNPs for four fetal-
hemoglobin QTLs (BCL11A, HMIP-2A, HMIP-2B, 
the beta-globin gene cluster) in 60 Colombian 
patients with sickle cell anemia. Alleles known to 
increase HbF levels in European and West African 
populations were detected at each locus. Patients 
carrying such alleles (heterozygotes) had, on 
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average, higher HbF levels than patients without 
these alleles, for all four SNPs investigated (table 
1), however, a formal test for genetic association 
did not reach statistical significance (in order to get 
it, we would probably have to increase the number 
of patients studied). Age was the only variable 
significantly associated with HbF (p=0.014) (result 
not shown).
The frequency of HbF-promoting alleles across 
the four loci is strikingly different (table 2) from 
that reported for West African, European and East 
Asian populations: The first QTL, the beta-globin 
gene cluster, is represented by rs7482144 (also 
called ‘Xmn I Gγ site’). This SNP is linked to the 
sickle mutation, and allele ‘A’ largely indicates 
the presence of the ‘Senegal’ sickle haplotype, 
known to be associated with higher HbF levels 
and milder disease. ‘A’ is somewhat more frequent 
in our patients than in the West African reference 
population YRI (0.123 vs. 0.074, not significant). 
This allele did not show differences with HCB 
population either (0.123 vs 0.113). 
The BCL11A locus is represented by SNP 
rs11886868, where the high-HbF (and protective) 
allele is ‘C’ in all populations studied so far (22,25-
27). In the Colombian samples, the two alleles have 
a nearly equal frequency (T=0.492 and C=0.508) 
(table 2). This is fundamentally different to what 
has been reported for West Africans or Europeans, 
where ‘C’ is the minor allele (with frequencies 
of 0.239 and 0.301, respectively), but also for 
East Asians (Han Chinese, HCB), where ‘C’ is 
predominant (at 0.930). Thus, Colombian patients 
seem to represent a situation at this locus where 
an ‘East-Asian like’ component is overlaid over 
West-African/European allele frequencies.
The HBS1L-MYB region contains two HbF QTLs, 
HMIP-2A and HMIP-2B (HBS1L-MYB intergenic 
polymorphisms A and B) (Menzel, et al., manuscript 
in preparation). HMIP-A is tagged by the SNP 
rs9399137, with the ‘C” allele promoting HbF. This 
allele is very rare in the Colombian patients, carried 
only by a single individual; rs9399137-‘C’ is also 
rare in the West-African YRI population sample 
(0.04), but significantly more common (p<0.01) in 
Chinese and Europeans. HMIP-B was tagged in our 
patients by rs4895441, where the HbF-promoting 
‘G’ allele was significantly more common (0.267 
vs. 0.066, p<0.05) than in the West African (YRI) 
population, but similar in frequency to the Chinese 
(HCB, 0.29) or European (CEU, 0.23) populations. 
The presence of rs4895441-‘G’ in individuals 
that lack rs9399137-‘C’ (a common situation in 
Colombian patients) is untypical for Europeans 
though, but characteristic in some East-Asian and 
Amerindian populations (Menzel, et al., manuscript 
in preparation).
Discussion
We investigated four major QTLs affecting HbF 
levels (the beta-globin gene cluster, BCL11A, 
Table 2. Distribution of allelic frequencies of SNPs evaluated. Population for comparison were the Han from China (HCB), Yoruba 
from Nigeria (YRI) and North-American from European origin (CEU).
SNP
Position 
(Chromosome)
Alleles
↓HbF/↑HbF***
Observed 
frecuency
Minor allele frequency
HCB YRI CEU
rs4895441
rs9399137
rs11886868
rs7482144**
135468266 (6)
135460711 (6)
  60573750 (2)
     5232745 (11)
A/G
T/C
T/C
G/A
0.733/0.267
0.992/0.008
0.492/0.508
0.877/0.123
0.291  (p=0.83)
0.238  (p=0.00)
  0.07* (p=0.00)
0.113  (p=0.92)
0.066 (p=0.00)
0.040 (p=0.20)
0.239 (p=0.00)
0.074 (p=0.11)
0.230 (p=0.44)
0.201 (p=0.00)
0.301 (p=0.00)
0.265 (p=0.00)
* In the Han population, the allele with the lowest frequency is T. This is different to the populations YRI and CEU, where T is the most frequent allele. 
** There wasn’t a register of rs7482144 in HapMap database. The frequency was taken from 1000 genomes panel database http://e75.ensembl.org/
Homo_sapiens/Variation/Citations db=core;r=11:5275669-5276669;v=rs7482144;vdb=variation;vf=5220906).
***↓HbF/↑HbF associated with levels of expression of HbF.
Table 1. Mean (%) HbF for genotypes in SNPs rs4895441, 
rs7482144, rs9399137, rs11886868
SNP Mean HbF (%)
Low/Low* Low/High High/High*
rs4895441
rs9399137
rs11886868
rs7482144
AA (n=34)
5.552
TT (n=59)
8.02 
TT(n=15)
6.13 
GG (n=43)
7.884
AG (n=22)
9.322 
TC (n=1)
9.5 
TC (n=29)
9.186
GA (n=12)
7.979 
GG (n=4)
7.919 
CC (n=0)
0
 CC (n=16)
7.771 
AA (n=1)
10 
* Low and high refer to the effect of these alleles on expression of HbF as 
registered in the literature.
The mean values of HbF can be observed under each genotype. 
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HMIP-2A, and HMIP-2B) in 60 Colombian patients 
with sickle cell disease. While our patient group 
was too small to formally show association with 
representative markers for these loci, we evaluated 
the frequency of HbF-promoting alleles to obtain 
a first overview of the genetic situation of patients 
with sickle cell disease in Colombia. 
The SNPs evaluated in this paper showed a strong 
association with the HbF levels in a wide spectrum 
of populations, including those from Europe, 
North America and Brazil where three joint QTLs 
(rs9399137, 4895441 y rs11886868) explain more 
than 20% of HbF variability (5,18,22). Therefore, 
they are suited to estimate the prevalence of HbF-
promoting alleles at these loci. 
Genotypes for rs7482144 represent West-African 
segments of chromosome 11 containing the beta-
globin locus and sickle mutation. The prevalence 
of allele ‘A’, tagging mostly the ‘Senegal’ sickle 
haplotype and a few atypical haplotypes (28), is 
due to the specific origin of the African ancestors of 
our patients, which might have included individuals 
from Senegal or Sierra Leone, where this allele is 
more frequent (29).
Alleles at the two regions unlinked to the sickle 
mutation, BCL11A and HBS1L-MYB (HMIP-A and 
HMIP-2B), showed allele frequencies that are 
distinctly non-African, suggesting a substantial 
influence of admixture in the genetic situation of 
sickle patients in Colombia.
At BCL11A, the high frequency of the rs11886868-
‘C’ high-HbF allele suggests the presence of a 
large East-Asian-like population component. This 
component is most likely of Amerindian nature since 
substantial similarities exist between some East 
Asian and Amerindian population groups (30).
At HMIP-2A, the high-HbF rs9399137-‘C’ allele was 
present in a single patient. This patient also carried 
rs4895441-‘G’ at HMIP-2B, indicating the presence 
of a ‘Eurasian haplotype’ (Menzel, et al., manuscript 
in preparation), which is not present in West Africa, 
but is likely to originate from Asian, European or 
Amerindian chromosomes; rs4895441-‘G’, on its 
own, was relatively frequent in our patients. This 
situation is characteristic for some East Asian, 
such as Japanese and Yakut, and Amerindian 
populations (Human Genome Diversity Panel 
(http://www.hagsc.org/hgdp/files.html).
These overall results are probably an indication 
of the genetic diversity shown by the Colombian 
population. The Colombian Amerindian population 
component is genetically complex, with large 
differences in allelic frequency among sub-
populations, possibly due to a strong genetic 
drift and small effective population sizes (31). In 
the pre-Columbian period, there were several 
Amerindian populations that maintained isolation 
from each other inhabiting the territory of today’s 
Colombia (32). In the present population from 
the Center and the South-West of Colombia, the 
presence of admixture and gene flow between 
different ethnical groups is well documented. Using 
markers for mtDNA, Rondón, et al., (33) showed 
that in individuals with African heritage, there were 
15% typical Amerindian haplotypes. In addition, 
complex admixture patterns have been observed 
in other population groups, such as indigenous and 
“mestizo” (i. e., of mixed descent) groups in the 
South-West of Colombia, but also in the European/
Amerindian admixed population of the Department 
of Antioquia (North-West of Colombia). This popu-
lation showed a high frequency of Amerindian 
haplotypes in mtDNA (77-100%). Regarding the Y 
chromosome, 94% was European, 5% African and 
1% Amerindian. These data suggest a model of 
admixture for this part of Colombia: Predominantly 
male European founders from Southern Spain and 
a female predominantly Amerindian contribution 
followed by isolation (34,35). Thus, the admixture 
between European, African, and Amerindian 
populations has a different extent in each region 
of Colombia. In the center and East of Colombia, 
European and Amerindian ancestry predominate; 
in coastal regions, European, Amerindian, and 
African ancestry all significantly contribute to the 
population (36). Specifically, our data indicate 
the presence of a large Amerindian admixture 
component in our patients, resulting in a compara-
tively high prevalence of HbF-promoting and 
disease-alleviating QTL alleles.
The results of this study show that sickle cell 
anemia patients have an appreciable admixture 
between people from African and Amerindian 
origins. This phenomenon is typical in Colombian 
population, and is the product of historical events 
that gave rise to it (37). When the Spaniards came 
to the actual Colombian territory, the Indian groups 
at both coasts were Arawaks and Caribes on the 
Caribbean Coast; and Embera, Weunana, and Cuna 
on the Pacific Coast (38). The first Africans arrived 
in America in 1525. This first group of slaves came 
from Senegal and Sierra Leone (Yolofo, Serere 
group) (39,40,41). The origin of these first slaves 
could explain the prevalent frequency of Senegal 
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allele at rs7482144. Subsequent organization of 
Afro Colombian communities in Palenques (isolated 
settlements of free people) allowed the breeding 
with Amerindian people present on coastal regions 
of Colombia. This admixture accounts for the 
observed allele frequency of SNPs assessed in 
this study.
An extension of studies reported here will require 
the enrollment of additional patients, enabling a 
detailed investigation of the relationship between 
QTL polymorphisms and HbF. Amerindian genes 
have not been studied extensively in connection 
with this trait, and different SNPs might be best 
suitable to tag HbF-promoting alleles with this 
specific ancestry. With their unique genetic back-
ground, Colombian patients are expected to yield 
a distinctive insight into the effect of modifier loci in 
sickle cell disease.
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